GKS Seeks Preemption Summary Judgment In 2-Month-Old Zofran MDL
BOSTON — Less than two months after the Zofran multidistrict litigation was created, GlaxoSmithKline LLC (GSK) on Dec. 11 filed a motion for summary judgment or dismissal on the grounds that...To view the full article, register now.
Already a subscriber? Click here to view full article